Clinical Case Studies in Diagnostics and Management of Clostridioides difficile Infection

Here’s my take on guideline changes that affect how we diagnose and treat primary and recurrent Clostridioides difficile infection.

Sahil Khanna, MBBS, MS Released: January 21, 2022

I think appropriate treatment of initial infection is our best opportunity to avoid the cycle of recurrent CDI—and now the guidelines agree.

Paul Feuerstadt, MD, FACG, AGAF Released: February 11, 2022

Understanding the role of treatment goals for initial CDI is critical. Here's what this means for you.

Kevin Garey, PharmD, MS Released: March 10, 2022

Why I’m excited about new guidelines for CDI―and why you should be, too.

Teena Chopra, MD, MPH Released: March 31, 2022

Hear expert insights on diagnostic strategies for CDI, effective and durable treatment strategies for initial CDI episodes, and management strategies for recurrent CDI, including rapid-fire clinical cases and engaging panel discussions.

Sahil Khanna, MBBS, MS
Program Director Teena Chopra, MD, MPH Paul Feuerstadt, MD, FACG, AGAF Kevin Garey, PharmD, MS Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Registered Nurses: 2.0 Nursing contact hours Pharmacists: 2.0 contact hours (0.2 CEUs) Released: April 5, 2022 Expired: April 4, 2023

Introduction

Epidemiology, Pathophysiology, Risk Factors, and Diagnosis

Key Data on Therapeutic Options for Initial C difficile Infection (CDI) Episodes

Recurrent CDI Episodes: The Latest Data and Recommendations on Therapeutic Options

Discussion and Conclusions

Comprehensive slideset featuring data on key concepts in CDI management, including epidemiology, pathophysiology, burden of disease, diagnostics, and optimizing treatment regimens to minimize the risk for recurrence.

Teena Chopra, MD, MPH Paul Feuerstadt, MD, FACG, AGAF Kevin Garey, PharmD, MS Sahil Khanna, MBBS, MS Released: February 14, 2022